These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 7850963

  • 1. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.
    Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M.
    Circulation; 1995 Feb 15; 91(4):1229-35. PubMed ID: 7850963
    [Abstract] [Full Text] [Related]

  • 2. Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney.
    Kakoki M, Hirata Y, Hayakawa H, Tojo A, Nagata D, Suzuki E, Kimura K, Goto A, Kikuchi K, Nagano T, Omata M.
    Circulation; 1999 Mar 09; 99(9):1242-8. PubMed ID: 10069794
    [Abstract] [Full Text] [Related]

  • 3. Long-term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats.
    Hayakawa H, Hirata Y, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M.
    Hypertension; 1994 Jun 09; 23(6 Pt 1):752-6. PubMed ID: 8206573
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
    Brakch N, Abdel-Sayed S, Allemandou F, Wang Q, Aubert JF, Brunner HR, Nussberger J.
    J Hypertens; 2004 Sep 09; 22(9):1797-803. PubMed ID: 15311109
    [Abstract] [Full Text] [Related]

  • 6. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD, Allcock GH, Corder R, Vane JR.
    Br J Pharmacol; 1993 Oct 09; 110(2):777-82. PubMed ID: 8242251
    [Abstract] [Full Text] [Related]

  • 7. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S.
    Br J Pharmacol; 1995 Mar 09; 114(5):925-30. PubMed ID: 7780646
    [Abstract] [Full Text] [Related]

  • 8. Central endothelin ETB receptor activation reduces blood pressure and catecholaminergic activity in the olfactory bulb of deoxycorticosterone acetate-salt hypertensive rats.
    Guil MJ, Soria C, Seijas M, Bianciotti LG, Vatta MS.
    Eur J Pharmacol; 2020 Oct 15; 885():173543. PubMed ID: 32896551
    [Abstract] [Full Text] [Related]

  • 9. Block of endothelin-1-induced release of thromboxane A2 from the guinea pig lung and nitric oxide from the rabbit kidney by a selective ETB receptor antagonist, BQ-788.
    D'Orléans-Juste P, Claing A, Télémaque S, Maurice MC, Yano M, Gratton JP.
    Br J Pharmacol; 1994 Dec 15; 113(4):1257-62. PubMed ID: 7889281
    [Abstract] [Full Text] [Related]

  • 10. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Dec 15; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 11. Role of endothelins in regulation of vascular tone in the in situ perfused rat adrenals.
    Mazzocchi G, Malendowicz LK, Musajo FG, Gottardo G, Markowska A, Nussdorfer GG.
    Am J Physiol; 1998 Jan 15; 274(1):E1-5. PubMed ID: 9458740
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
    Pollock DM, Allcock GH, Krishnan A, Dayton BD, Pollock JS.
    Am J Physiol Renal Physiol; 2000 Feb 15; 278(2):F279-86. PubMed ID: 10662732
    [Abstract] [Full Text] [Related]

  • 13. Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ET(B) receptor-mediated vascular responses.
    Tostes Passaglia RC, David FL, Fortes ZB, Nigro D, Scivoletto R, Catelli De Carvalho MH.
    Br J Pharmacol; 2000 Jul 15; 130(5):1092-8. PubMed ID: 10882394
    [Abstract] [Full Text] [Related]

  • 14. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
    Molero MM, Giulumian AD, Reddy VB, Ludwig LM, Pollock JS, Pollock DM, Rusch NJ, Fuchs LC.
    J Hypertens; 2002 Sep 15; 20(9):1799-805. PubMed ID: 12195122
    [Abstract] [Full Text] [Related]

  • 15. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
    David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC.
    Hypertension; 2001 Sep 15; 38(3 Pt 2):692-6. PubMed ID: 11566958
    [Abstract] [Full Text] [Related]

  • 16. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
    Ivy DD, Kinsella JP, Abman SH.
    J Clin Invest; 1994 May 15; 93(5):2141-8. PubMed ID: 8182146
    [Abstract] [Full Text] [Related]

  • 17. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M.
    Hypertension; 1999 Feb 15; 33(2):759-65. PubMed ID: 10024341
    [Abstract] [Full Text] [Related]

  • 18. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ, Fink GD, Watts SW, Galligan JJ.
    J Hypertens; 2002 Apr 15; 20(4):665-76. PubMed ID: 11910302
    [Abstract] [Full Text] [Related]

  • 19. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD, Allcock GH, Vane JR.
    Br J Pharmacol; 1994 May 15; 112(1):207-13. PubMed ID: 8032643
    [Abstract] [Full Text] [Related]

  • 20. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R, Sventek P, Thibault G, Schiffrin EL.
    Can J Physiol Pharmacol; 1995 Mar 15; 73(3):390-8. PubMed ID: 7544236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.